克罗恩病患儿生长障碍存在性别特异性通路
该前瞻性多中心纵向队列研究纳入122例克罗恩病患儿(63%为男性),通过计算基于实际年龄与基于骨龄的身高Z评分差值评估生长障碍,并检测血清细胞因子与激素水平。女性中IL-8、IL-12p70、干扰素-γ与性激素及胰岛素样生长因子1轴负相关,男性中IL-1β和IL-6与胰岛素样生长因子1轴负相关。
要点
- 克罗恩病患儿中女性身高Z评分差值大于男性,提示女性生长相对优于男性。
- 女性中IL-8、IL-12p70和干扰素-γ与下丘脑-垂体-性腺轴及IGF-1轴负相关。
- 男性中IL-1β和IL-6与IGF-1轴负相关。
核心结论
- 克罗恩病患儿生长障碍存在性别特异性分子通路,男性主要涉及生长激素/胰岛素样生长因子-1轴,女性主要涉及下丘脑-垂体-性腺轴。
研究设计与样本
- 前瞻性多中心纵向队列研究,纳入122例克罗恩病儿童和青少年(63%为男性),共完成594次访视,平均实际年龄11.70±1.79岁。
主要发现
- 男性基于实际年龄的身高Z评分为-0.03±0.99,女性为-0.49±0.87;男性基于骨龄的身高Z评分为0.23±0.93,女性为0.37±0.96。
临床怎么用
- 临床评估克罗恩病患儿生长障碍时需考虑性别差异,男性重点监测生长激素/IGF-1轴,女性关注下丘脑-垂体-性腺轴。
- 针对特定炎症细胞因子(如女性IL-8、IL-12p70、干扰素-γ,男性IL-1β、IL-6)的性别特异性治疗策略可能有助于改善生长障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the underlying mechanisms that lead growth impairment to occur more commonly in males than females with Crohn's disease (CD). STUDY DESIGN: Children and adolescents with CD were enrolled in a prospective multicenter longitudinal cohort study. Height Z-score difference was computed as height Z-score based on chronological age (height chronological age-Z-score) minus height Z-score based on bone age (height bone age-Z-score) using longitudinal data. Specific serum cytokines were measured, hormone Z-scores were calculated based on bone age (bone age-Z), and their longitudinal associations were examined. RESULTS: There were 122 children with CD (63% male) who completed 594 visits. The mean ± SD chronological age was 11.70 ± 1.79 years. The mean ± SD height chronological age-Z-score was -0.03 ± 0.99 in males and -0.49 ± 0.87 in females. The mean ± SD height bone age-Z-score was 0.23 ± 0.93 in males and 0.37 ± 0.96 in females. The magnitude of the mean height Z-score difference was greater in females (-0.87 ± 0.94) than males (-0.27 ± 0.90; P = .005), indicating growth was better in females than males. The following negative associations were identified: in females, interleukin (IL)-8 (P < .001) and IL-12p70 (P = .035) with gonadotropin-bone age-Z-scores; IL-8 (P = .010), IL-12p70 (P = .020), and interferon-γ (P = .004) with sex hormone-bone age-Z-scores, and IL-8 (P = .044) and interferon-γ (P < .001) with insulin-like growth factor 1-bone age-Z-scores; in males, IL-1 beta (P = .019) and IL-6 (P = .025) with insulin-like growth factor 1-bone age-Z-scores. CONCLUSIONS: Our data suggest that sex-specific molecular pathways lead to growth impairment in children with CD (primarily growth hormone/insulin-like growth factor-1 axis in males and primarily hypothalamic-pituitary-gonadal axis in females). Mapping these sex-specific molecular pathways may help in the development of sex-specific treatment approaches targeting the underlying inflammation characteristic of CD.
引用
- Gupta N, Lustig RH, Andrews H, et al. Sex-Specific Pathways Lead to Statural Growth Impairment in Children with Crohn's Disease. J Pediatr. 2022. PMID: 35649448. doi:10.1016/j.jpeds.2022.05.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。